Atriopeptins: correlation between renal vasodilation and natriuresis.

Area of Science:

• Nephrology
• Cardiovascular Physiology
• Endocrinology

Background:

• Atrial peptides are endogenous hormones with known cardiovascular and renal effects.
• Understanding their specific actions on renal function is crucial for physiological and therapeutic insights.

Purpose of the Study:

• To investigate the effects of various atrial peptides on renal function in vivo.
• To establish a rank order of potency for atrial peptides as renal vasodilators and natriuretic agents.
• To correlate renal functional changes with peptide administration routes and doses.

Main Methods:

• Quantitative comparison of bolus intra-arterial injections of different atrial peptides in anesthetized dogs.
• Sustained intra-arterial and intravenous infusions of atriopeptin III to assess dose- and time-dependent effects.
• Monitoring of renal blood flow, urine volume, sodium excretion, osmotic clearance, systemic blood pressure, and heart rate.

Main Results:

• A clear rank order of potency was established: ser-leu-arg-arg-atriopeptiin III > high molecular weight atrial peptide >= atriopeptin III = atriopeptin II >> atriopeptin I.
• Both intra-arterial and intravenous administration of atriopeptin III induced concentration-dependent increases in renal blood flow, urine volume, and sodium excretion.
• Intra-arterial infusion of atriopeptin III did not affect systemic blood pressure or heart rate, whereas intravenous infusion required higher doses and caused hypotension and tachycardia.

Conclusions:

• Atrial peptides, particularly atriopeptin III, are potent renal vasodilators and natriuretic/diuretic agents.
• The natriuretic-diuretic effect is closely associated with renal vasodilation, showing a positive linear correlation with changes in renal blood flow.
• Route and dose of administration significantly influence systemic cardiovascular effects.